"Designing Growth Strategies is in our DNA"
Anti-infective drugs or agents are capable of acting against an infection, by inhibiting the spread of an infectious agent or by killing the infectious agent. The infection causing agents include fungi, virus, bacteria, and macro parasites. Factors such as increase in the number of patients suffering from infectious diseases, extensive research and development efforts pertaining to the development of new drugs, rise in the new drug approvals, and growing awareness among the individuals related to the infectious diseases are expected to accentuate the market growth during the forecast period. For example, in August 2019, Nabriva Therapeutics received USFDA approval for Xenleta (lefamulin), new antibiotic to treat adults with community-acquired bacterial pneumonia.
The anti-infective drugs market is expected to register a significant growth during the forecast period due to factors such rising number of cases of infectious diseases, escalating health-consciousness, growing number of product approvals for the treatment of infectious diseases. However, high cost of the drugs and poor reimbursement policies are the major factors anticipated to hamper the growth of anti-infective drugs market.
Key Market Driver -
Rising prevalence of infectious diseases, rise in drug approvals for the treatment
Key Market Restraint -
High cost of the drugs, poor reimbursement policies
Globally, the anti-infective drugs market can be segmented on the basis of the drug type, indication, route of administration, distribution channel and region. Based on the drug type, the market can be segmented into antibiotics, antivirals, antifungals, and others. Based on indication, the market can be segmented into HIV, pneumonia, respiratory infections, tuberculosis, and others. Based on the route of administration, the market can be segmented into oral, topical, and parenteral. Based on distribution channel, the market can be segmented into hospital pharmacies, retail pharmacies, and others. Geographically, the anti-infective drugs market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
Some of the major companies that are present in the anti-infective drugs market are Pfizer Inc., Merck & Co., Inc. Bristol-Myers Squibb Company, Abbott, Novartis AG, Johnson & Johnson Services Inc., Gilead Sciences, Inc., and Astellas Pharma Inc. GlaxoSmithKline plc., Sanofi, and other prominent players.
To gain extensive insights into the market, Request for Customization
Geographically, the anti-infective drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to account for maximum share of the anti-infective drugs market. The dominance is attributable to the increasing incidence of infectious diseases, well developed healthcare sector, and high purchasing power for expensive drugs. For instance, according to Center for Disease Control and Prevention, more than 250,000 people in U.S. are diagnosed with pneumonia every year. Europe is expected to hold second largest market share in global market. Increasing geriatric population and highly aware population is likely to spur the market growth in this region. On the other hand, Asia Pacific is expected to register the highest CAGR owing to the rising economic stability, growing awareness among the population and rising prevalence of infectious diseases. The market in Latin America and the Middle East & Africa are in nascent stage. However, growing geriatric population coupled with increasing susceptibility to infectious diseases in these regions are likely to help witness a considerable growth in the market in the upcoming years.
By Drug Type
By Route Of Administration
By Distribution Channel
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry